CCL2 and breast cancer: Comparison of curves for low MCP‐1 and high MCP‐1 groups showed that patients with ER− breast cancers with low MCP‐1 expression were at increased risk of breast cancer‐related death with distant relapse (p < 0.01; Figure 2B).